The monoclonal antibody (mAb) therapeutics market has seen explosive growth in recent years, becoming one of the most significant segments of the biopharmaceutical industry. Monoclonal antibodies (mAbs) are laboratory-made molecules designed to mimic the immune system’s ability to fight off harmful pathogens such as viruses and bacteria. These therapeutic agents have become vital...
English
Arabic
Español
Português
Deutsch
Türkçe
Dutch
Italiano
Russian
Romaian